Skip to main content
. 2016 Aug 29;27(11):2032–2038. doi: 10.1093/annonc/mdw317

Figure 1.

Figure 1.

Enrollment of cancer patients to two placebo-controlled randomized trials (studies: NCT00401362 and NCT00672477) of methylnaltrexone (MNTX) in patients with advanced illnesses treated with regular opioids with opioid-induced constipation.